TapImmune, Inc. at the 2010 OneMedForum
Denis Corin, President of TapImmune, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Month: January 2010
Jeff Eliot Margolis CFO of Xintria Pharmaceutical Corporation
Jeff Eliot Margolis, CFO of Xintria Pharmaceutical Corporation, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Echo Therapeutics Rated Strong Spec Buy by Life Tech Capital
The significant differences between Echo Therapeutics’ Symphony system and the competition is the needle-free transdermal biosensor, clinical trials in the hospital setting and biosensor life.
[OneMedForum] Biomoda’s Platform for Early Cancer Detection
Biomoda’s CyPath diagnostic assay is based on molecular marker technology originally developed at the Los Alamos National Laboratory.
Genomic Health’s Colon Cancer Test Goes Worldwide
Genomic Health, a developer of genomics-based diagnostic tests, announced on Thursday the worldwide availability of its Oncotype DX Colon Cancer Test.
Ampyra Walks Away with FDA Approval
The U.S. Food and Drug Administration (FDA) has approved the first drug designed to improve walking in adults with multiple sclerosis.
Depomed Rallies for Another Round with Serada
After receiving guidance from U.S. regulators, pharmaceutical company Depomed has announced a late-stage trial of its drug candidate for menopausal hot flashes.
Access Pharma’s Drug Delivery Technology Is a Stealth Asset
Access Pharma (OTC: ACCP.OB) provided an update today on the status of its cobalamin-based oral drug delivery product development programs.
Healthcare Conference Updates: AUXL, CTIC, CYTX, KERX
Below are some updates and developments from the past week.
[OneMedForum] NuVue Therapeutics’ Multi-Step Approach to Cancer Therapy
NuVue Therapeutics is commercializing a site-specific regimen of cancer therapy for soft tissue tumors.